Pimozide

匹莫齐特

Report date: 2024/11/11 20:00:37
NME

Base Information

Drug NamePimozide
Drug Alias NamePimozidum匹莫奇特双氟苯丁哌啶苯并咪唑酮pimozida匹莫静 +[11] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAdrenergic receptors antagonistsDopamine receptors antagonists
TargetsAdrenergic receptorsDopamine receptors
Therapy Area/IndicationsAmyotrophic Lateral SclerosisTourette Syndrome
Global Approved IndicationsTourette Syndrome
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date1984/07/31
Country/TerritoryCanadaUnited States
CombinationsNo
Global Highest StatusWithdrawn
Highest Status in ChinaN/A
Originator CompaniesTeva
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesUniversity Of CalgaryTeva Pharmaceutical Industries LtdNational Center For Research Resources
Active IndicationsN/A
Inactive IndicationsAmyotrophic Lateral SclerosisTourette Syndrome

Other Information

ATC CodeN05AG02
Related LinksWikipediaDrugBankKEGG